Publications

1. Malik DG, Ferrigni RG, Yang M. Identification of Bladder Diverticular Stone on (99m)Tc-MDP Bone Scintigraphy and SPECT/CT. J Nucl Med Technol. 2020 Jun 9 Epub 2020 June 09
   View PubMed
2. Faraj KS, Mi L, Eversman S, Singh R, DeLucia NM, Blodgett G, Swanson SK, Andrews PE, Ferrigni RG, Humphreys MR, Castle EP, Tyson MD 2nd. The effect of urinary diversion on long-term kidney function after cystectomy. Urol Oncol. 2020 May 29 [Epub ahead of print]
   View PubMed
3. Navaratnam A, Cumsky J, Abdul-Muhsin H, Gagneur J, Shen J, Kosiorek H, Golafshar M, Kawashima A, Wong W, Ferrigni R, Humphreys MR. Assessment of Polyethylene Glycol Hydrogel Spacer and Its Effect on Rectal Radiation Dose in Prostate Cancer Patients Receiving Proton Beam Radiation Therapy. Adv Radiat Oncol. 2020 Jan-Feb; 5 (1):92-100 Epub 2019 Sept 05
   View PubMed
4. Blaine SA, Abdul-Muhsin HM, Jakob NJ, Andrews PE, Ferrigni RG, Cha SS, Golshani A, Silva AC, Kawashima A, Humphreys MR. MRI - ultrasound fusion guided biopsy of the prostate: lesion volume as a predictor of cancer in patients with repeat biopsies. Indian J Urol. 2019 Jul-Sep; 35 (3):208-212
   View PubMed
5. Ashfaq A, Ferrigni R, Mishra N. Laparoscopic approach to colo-renal fistula with renal preservation and omentoplasty: A case report. Int J Surg Case Rep. 2017; 35:53-56 Epub 2017 Apr 04
   View PubMed
6. Abdul-Muhsin HM, Tyson MD, Andrews PE, Castle EP, Ferrigni RG, Wolter CE, Swanson SK, McLemore RY, Humphreys MR. Analysis of Benign Prostatic Hyperplasia Patients' Perspective Through a Third Party-administered Survey. Urology. 2016 Feb; 88:155-60.
   View PubMed
7. Wisenbaugh ES, Andrews PE, Ferrigni RG, Schild SE, Keole SR, Wong WW, Vora SA. Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Rev Urol. 2014; 16 (2):67-75
   View PubMed
8. Vora SA, Wong WW, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer. J Urol. 2013 Aug; 190(2):521-6. Epub 2013 Feb 13.
   View PubMed
9. Tyson MD, Andrews PE, Etzioni DA, Ferrigni RG, Humphreys MR, Swanson SK, Castle EK. Marital status and prostate cancer outcomes. Can J Urol. 2013 Apr; 20(2):6702-6.
   View PubMed
10. Tyson MD, Etzioni DA, Wisenbaugh ES, Andrews PE, Humphreys MR, Ferrigni RG, Swanson SK, Castle EP. Anatomic site-specific disparities in survival outcomes for penile squamous cell carcinoma. Urology. 2012 Apr; 79 (4):804-8 Epub 2012 Mar 03
    View PubMed
11. Warner JN, Nunez RN, Mmeje CO, Colby TV, Ferrigni RG, Humphreys MR, Andrews PE, Castle EP. Impact of margin status at 37 months after robot assisted radical prostatectomy. Can J Urol. 2011 Dec; 18(6):6043-9.
    View PubMed
12. Nakamura LY, Nunez RN, Andrews PE, Ferrigni RG, Humphreys MR, Swanson SK, Wolter CE, Castle EP. Older age does not impact perioperative complications after robot-assisted radical prostatectomy. J Robot Surg. 2011 Sep; 5 (3):201-8 Epub 2011 Feb 05
    View PubMed
13. Chauhan S, Patel MB, Coelho R, Liss M, Rocco B, Sivaraman AK, Palmer KJ, Coughlin GD, Ferrigni RG, Castle EP, Ahlering TE, Parra-Davila E, Patel VR. Preliminary analysis of the feasibility and safety of salvage robot-assisted radical prostatectomy after radiation failure: multi-institutional perioperative and short-term functional outcomes. J Endourol. 2011 Jun; 25(6):1013-9. Epub 2011 May 13.
    View PubMed
14. Nakamura LY, Ferrigni RG, Stone WM, Fowl RJ. Urinary bladder injuries during vascular surgery. J Vasc Surg. 2010 Aug; 52: (2)453-5.
    View PubMed
15. Nunez-Nateras R, Andrews JR, Martin GL, Andrews PE, Humphreys MR, Ferrigni RG, Eversman WG, Castle EP. Accuracy of ultrasound in estimation of prostate weight: comparison of urologists and radiologists. Can J Urol. 2010 Feb; 17: (1)4985-8.
    View PubMed
16. Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy. Cancer. 2009 Dec 1; 115(23):5596-606.
    View PubMed
17. Martin GL, Nunez RN, Humphreys MD, Martin AD, Ferrigni RG, Andrews PE, Castle EP. Interval from prostate biopsy to robot-assisted radical prostatectomy: effects on perioperative outcomes. BJU Int. 2009 Dec; 104(11):1734-7. Epub 2009 Jun 22.
    View PubMed
18. Martin AD, Desai PJ, Nunez RN, Martin GL, Andrews PE, Ferrigni RG, Swanson SK, Pacelli A, Castle EP. Does a history of previous surgery or radiation to the prostate affect outcomes of robot-assisted radical prostatectomy? BJU Int. 2009 Jun; 103(12):1696-8. Epub 2008 Dec 23
    View PubMed
19. Conley SP, Humphreys MR, Desai PJ, Castle EP, Dueck AC, Ferrigni RG, Andrews PE. Laparoscopic radical nephrectomy for very large renal tumors (> or =10 cm): is there a size limit? J Endourol. 2009 Jan; 23: (1)57-61.
    View PubMed
20. Martin GL, Castle EP, Martin AD, Desai PJ, Lallas CD, Ferrigni RG, Andrews PE. Outcomes of laparoscopic radical nephrectomy in the setting of vena caval and renal vein thrombus: seven-year experience. J Endourol. 2008 Aug; 22: (8)1681-5.
    View PubMed
21. Woods M, Thomas R, Davis R, Andrews PE, Ferrigni RG, Cheng J, Castle EP. Robot-assisted extended pelvic lymphadenectomy. J Endourol. 2008 Jun; 22(6):1297-302.
    View PubMed
22. Desai PJ, Castle EP, Daley SM, Swanson SK, Ferrigni RG, Humphreys MR, Andrews PE. Bilateral laparoscopic nephrectomy for significantly enlarged polycystic kidneys: a technique to optimize outcome in the largest of specimens. BJU Int. 2008 Apr; 101(8):1019-23. Epub 2008 Jan 10.
    View PubMed
23. Desai PJ, Andrews PE, Ferrigni RG, Castle EP. Laparoscopic partial nephrectomy at the Mayo Clinic Arizona: follow-up surveillance of positive margin disease. Urology. 2008 Feb; 71(2):283-6.
    View PubMed
24. Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, Collie AC, Ferrigni RG, Myers RP, Prussak KA, Heckman MG, Crook JE, Parker AS, Igel TC. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. J Urol. 2006 Sep; 176: (3)985-90.
    View PubMed
25. Roarke MC, Ferrigni R, Ram P, Nguyen BD. Ureteropelvic junction obstruction caused by incisional lumbar hernia: preoperative evaluation by diuretic renal scintigraphy. Clin Nucl Med. 2005 Dec; 30 (12):823-6
    View PubMed
26. Castle EP, Andrews PE, Itano N, Novicki DE, Swanson SK, Ferrigni RG. The male sling for post-prostatectomy incontinence: mean followup of 18 months. J Urol. 2005 May; 173(5):1657-60.
    View PubMed
27. Simon SD, Castle EP, Ferrigni RG, Andrews PE. Routine postoperative chest x-ray following laparoscopic nephrectomy. JSLS. 2005 Apr-Jun; 9 (2):205-7
    View PubMed
28. MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? Urology. 2004 Oct; 64(4):760-4.
    View PubMed
29. Stern JA, Simon SD, Ferrigni RG, Andrews PE. TissueLink (TM) device for laparoscopic nephron-sparing surgery. J Endourol. 2004 Jun; 18(5):455-6.
    View PubMed
30. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2004 Apr 1; 58(5):1530-5.
    View PubMed
31. Simon SD, Castle EP, Ferrigni RG, Lamm DL, Swanson SK, Novicki DE, Andrews PE. Complications of laparoscopic nephrectomy: the Mayo clinic experience. J Urol. 2004 Apr; 171(4):1447-50.
    View PubMed
32. Simon SD, Ferrigni RG, Novicki DE, Lamm DL, Swanson SS, Andrews PE. Mayo Clinic Scottsdale Experience with laparoscopic nephroureterectomy. JSLS. 2004 Apr-Jun; 8 (2):109-13
    View PubMed
33. Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy. J Urol. 2003 Nov; 170(5):1833-7.
    View PubMed
34. Simon SD, Ferrigni RG, Novicki DE, Lamm DL, Swanson SS, Andrews PE. Mayo Clinic Scottsdale experience with laparoscopic nephron sparing surgery for renal tumors. J Urol. 2003 Jun; 169(6):2059-62.
    View PubMed
35. Hammitt DG, Ferrigni RG, Sattler CA, Rebert JA, Singh AP. Development of a new and efficient laboratory method for processing testicular sperm. J Assist Reprod Genet. 2002 Jul; 19 (7):335-42
    View PubMed
36. Weinmeister KP, Muir JJ, Ferrigni RG. Pulmonary thromboembolism during transurethral resection of the prostate. South Med J. 2000 Apr; 93(4):436-8.
    View PubMed
37. Pisansky TM, Kozelsky TF, Myers RP, Hillman DW, Blute ML, Buskirk SJ, Cheville JC, Ferrigni RG, Schild SE. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol. 2000 Mar; 163(3):845-50.
    View PubMed
38. Novicki DE, Larson TR, Andrews PE, Swanson SK, Ferrigni RG. Comparison of the modified vest and the direct anastomosis for radical retropubic prostatectomy. Urology. 1997 May; 49(5):732-6.
    View PubMed
39. Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 1996 Nov; 156(5):1725-9.
    View PubMed
40. Schild SE, Wong WW, Novicki DE, Ferrigni RG, Swanson SK. Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx PSA assay. Urology. 1996 Jun; 47(6):878-81.
    View PubMed
41. Buskirk SJ, Schild SE, Durr ED, Robinow JS, Bock FF, Wolfe JT, Tomera KM, Ferrigni RG. Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, N0 prostate cancer. Mayo Clin Proc. 1996 Mar; 71 (3):242-8
    View PubMed
42. Schild SE, Wong WW, Grado GL, Halyard MY, Novicki DE, Swanson SK, Larson TR, Ferrigni RG. The result of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34 (3):535-41
    View PubMed
43. Padma-Nathan H, Auerbach SM, Barada JH, Ferrigni RG, et al. Multicenter double-blind, placebo-controlled trial of transurethral Alprostadil in men with chronic erectile dysfunction. J Urol. 1995; 5:155.
    
44. Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, Frick LM, Ferrigni RG. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc. 1994 Jul; 69 (7):613-9
    View PubMed
45. Schild SE, Buskirk SJ, Robinow JS, Tomera KM, Ferrigni RG, Frick LM. The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy. Int J Radiat Oncol Biol Phys. 1992; 23 (1):141-5
    View PubMed
46. Guthman DA, Farrow GM, Myers RP, Ferrigni RG, Lieber MM. Adenocarcinoma of the prostate involving 2 cell types (prostate specific antigen producing and carcinoembryonic antigen producing) with selective metastatic spread. J Urol. 1991 Sep; 146 (3):854-6
    View PubMed
47. Johnson DW, Kessler JF, Ferrigni RG, Anderson JD. Low dose combined chemotherapy/radiotherapy in management of locally advanced urethral squamous-cell carcinoma. Journal of Urology. 1989; 141(3):615.
    View PubMed
48. Bartowski DP, Ferrigni RG. Castleman's disease: an unusual retroperitoneal mass. J Urol. 1988 Jan; 139(1):118-20.
    View PubMed
49. Ferrigni RG, Novicki DE. Chylous ascites complicating genitourinary oncological surgery. J Urol. 1985 Oct; 134(4):774-6.
    View PubMed